This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Botulinum neurotoxin
From Proteopedia
(Difference between revisions)
| Line 9: | Line 9: | ||
*'''Botulinum neurotoxin type D''' inhibits the release of TNF from monocytes.<br /> | *'''Botulinum neurotoxin type D''' inhibits the release of TNF from monocytes.<br /> | ||
*'''Botulinum neurotoxin type E, F and G''' act on human proteins of the neuroexocytosis apparatus.<br /> | *'''Botulinum neurotoxin type E, F and G''' act on human proteins of the neuroexocytosis apparatus.<br /> | ||
| + | *'''Botulinum neurotoxin type X''' cleaves both canonical and non-canonical vescicle-associated membrane proteins.<br /> | ||
== Disease == | == Disease == | ||
Revision as of 10:19, 2 April 2018
| |||||||||||
3D structures of botulinum neurotoxin
Updated on 02-April-2018
References
- ↑ Montecucco C, Molgo J. Botulinal neurotoxins: revival of an old killer. Curr Opin Pharmacol. 2005 Jun;5(3):274-9. PMID:15907915 doi:http://dx.doi.org/10.1016/j.coph.2004.12.006
- ↑ Lacy DB, Tepp W, Cohen AC, DasGupta BR, Stevens RC. Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat Struct Biol. 1998 Oct;5(10):898-902. PMID:9783750 doi:10.1038/2338
